• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aegerion Pharmaceuticals Inc

+ Add to Watchlist

AEGR:US

22.8100 USD 0.1400 0.61%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Aegerion Pharmaceuticals Inc (AEGR)

Open: 22.9200 Day's Range: 22.4800 - 23.5700 Volume: 1,458,789
Previous Close: 22.9500 52wk Range: 19.1000 - 74.5750 1-Yr Rtn: -65.14%

Stock Chart for AEGR

No chart data available.
  • AEGR:US 22.8100
  • 1D
  • 1M
  • 1Y
22.9500
Interactive AEGR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEGR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5454
Est. EPS (USD) (12/2014) -0.9630
Est. PEG Ratio -
Market Cap (M USD) 648.63
Shares Outstanding (M) 28.44
30 Day Average Volume 767,655
Price/Book (mrq) 4.0159
Price/Sale (ttm) 5.0896
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEGR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEGR

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.

Marc D BeerChief Executive OfficerMark J FitzpatrickChief Financial Officer
Craig FraserChief Operating OfficerMark SumerayChief Medical Officer
More Company Profile & Key Executives for AEGR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil